Cargando…

Biochemical markers of bone turnover and their association with bone marrow lesions

INTRODUCTION: Our objective was to determine whether markers of bone resorption and formation could serve as markers for the presence of bone marrow lesions (BMLs). METHODS: We conducted an analysis of data from the Boston Osteoarthritis of the Knee Study (BOKS). Knee magnetic resonance images were...

Descripción completa

Detalles Bibliográficos
Autores principales: Hunter, David J, LaValley, Michael, Li, Jiang, Bauer, Doug C, Nevitt, Michael, DeGroot, Jeroen, Poole, Robin, Eyre, David, Guermazi, Ali, Gale, Daniel, Totterman, Saara, Felson, David T
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2575616/
https://www.ncbi.nlm.nih.gov/pubmed/18759975
http://dx.doi.org/10.1186/ar2494
_version_ 1782160343905075200
author Hunter, David J
LaValley, Michael
Li, Jiang
Bauer, Doug C
Nevitt, Michael
DeGroot, Jeroen
Poole, Robin
Eyre, David
Guermazi, Ali
Gale, Daniel
Totterman, Saara
Felson, David T
author_facet Hunter, David J
LaValley, Michael
Li, Jiang
Bauer, Doug C
Nevitt, Michael
DeGroot, Jeroen
Poole, Robin
Eyre, David
Guermazi, Ali
Gale, Daniel
Totterman, Saara
Felson, David T
author_sort Hunter, David J
collection PubMed
description INTRODUCTION: Our objective was to determine whether markers of bone resorption and formation could serve as markers for the presence of bone marrow lesions (BMLs). METHODS: We conducted an analysis of data from the Boston Osteoarthritis of the Knee Study (BOKS). Knee magnetic resonance images were scored for BMLs using a semiquantitative grading scheme. In addition, a subset of persons with BMLs underwent quantitative volume measurement of their BML, using a proprietary software method. Within the BOKS population, 80 people with BMLs and 80 without BMLs were selected for the purposes of this case-control study. Bone biomarkers assayed included type I collagen N-telopeptide (NTx) corrected for urinary creatinine, bone-specific alkaline phosphatase, and osteocalcin. The same methods were used and applied to a nested case-control sample from the Framingham study, in which BMD assessments allowed evaluation of this as a covariate. Logistic regression models were fit using BML as the outcome and biomarkers, age, sex, and body mass index as predictors. An receiver operating characteristic curve was generated for each model and the area under the curve assessed. RESULTS: A total of 151 subjects from BOKS with knee OA were assessed. The mean (standard deviation) age was 67 (9) years and 60% were male. Sixty-nine per cent had maximum BML score above 0, and 48% had maximum BML score above 1. The only model that reached statistical significance used maximum score of BML above 0 as the outcome. Ln-NTx (Ln is the natural log) exhibited a significant association with BMLs, with the odds of a BML being present increasing by 1.4-fold (95% confidence interval = 1.0-fold to 2.0-fold) per 1 standard deviation increase in the LnNTx, and with a small partial R(2 )of 3.05. We also evaluated 144 participants in the Framingham Osteoarthritis Study, whose mean age was 68 years and body mass index was 29 kg/m(2), and of whom 40% were male. Of these participants 55% had a maximum BML score above 0. The relationship between NTx and maximum score of BML above 0 revealed a significant association, with an odds ratio fo 1.7 (95% confidence interval = 1.1 to 2.7) after adjusting for age, sex, and body mass index. CONCLUSIONS: Serum NTx was weakly associated with the presence of BMLs in both study samples. This relationship was not strong and we would not advocate the use of NTx as a marker of the presence of BMLs.
format Text
id pubmed-2575616
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-25756162008-10-29 Biochemical markers of bone turnover and their association with bone marrow lesions Hunter, David J LaValley, Michael Li, Jiang Bauer, Doug C Nevitt, Michael DeGroot, Jeroen Poole, Robin Eyre, David Guermazi, Ali Gale, Daniel Totterman, Saara Felson, David T Arthritis Res Ther Research Article INTRODUCTION: Our objective was to determine whether markers of bone resorption and formation could serve as markers for the presence of bone marrow lesions (BMLs). METHODS: We conducted an analysis of data from the Boston Osteoarthritis of the Knee Study (BOKS). Knee magnetic resonance images were scored for BMLs using a semiquantitative grading scheme. In addition, a subset of persons with BMLs underwent quantitative volume measurement of their BML, using a proprietary software method. Within the BOKS population, 80 people with BMLs and 80 without BMLs were selected for the purposes of this case-control study. Bone biomarkers assayed included type I collagen N-telopeptide (NTx) corrected for urinary creatinine, bone-specific alkaline phosphatase, and osteocalcin. The same methods were used and applied to a nested case-control sample from the Framingham study, in which BMD assessments allowed evaluation of this as a covariate. Logistic regression models were fit using BML as the outcome and biomarkers, age, sex, and body mass index as predictors. An receiver operating characteristic curve was generated for each model and the area under the curve assessed. RESULTS: A total of 151 subjects from BOKS with knee OA were assessed. The mean (standard deviation) age was 67 (9) years and 60% were male. Sixty-nine per cent had maximum BML score above 0, and 48% had maximum BML score above 1. The only model that reached statistical significance used maximum score of BML above 0 as the outcome. Ln-NTx (Ln is the natural log) exhibited a significant association with BMLs, with the odds of a BML being present increasing by 1.4-fold (95% confidence interval = 1.0-fold to 2.0-fold) per 1 standard deviation increase in the LnNTx, and with a small partial R(2 )of 3.05. We also evaluated 144 participants in the Framingham Osteoarthritis Study, whose mean age was 68 years and body mass index was 29 kg/m(2), and of whom 40% were male. Of these participants 55% had a maximum BML score above 0. The relationship between NTx and maximum score of BML above 0 revealed a significant association, with an odds ratio fo 1.7 (95% confidence interval = 1.1 to 2.7) after adjusting for age, sex, and body mass index. CONCLUSIONS: Serum NTx was weakly associated with the presence of BMLs in both study samples. This relationship was not strong and we would not advocate the use of NTx as a marker of the presence of BMLs. BioMed Central 2008 2008-08-29 /pmc/articles/PMC2575616/ /pubmed/18759975 http://dx.doi.org/10.1186/ar2494 Text en Copyright © 2008 Hunter et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Hunter, David J
LaValley, Michael
Li, Jiang
Bauer, Doug C
Nevitt, Michael
DeGroot, Jeroen
Poole, Robin
Eyre, David
Guermazi, Ali
Gale, Daniel
Totterman, Saara
Felson, David T
Biochemical markers of bone turnover and their association with bone marrow lesions
title Biochemical markers of bone turnover and their association with bone marrow lesions
title_full Biochemical markers of bone turnover and their association with bone marrow lesions
title_fullStr Biochemical markers of bone turnover and their association with bone marrow lesions
title_full_unstemmed Biochemical markers of bone turnover and their association with bone marrow lesions
title_short Biochemical markers of bone turnover and their association with bone marrow lesions
title_sort biochemical markers of bone turnover and their association with bone marrow lesions
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2575616/
https://www.ncbi.nlm.nih.gov/pubmed/18759975
http://dx.doi.org/10.1186/ar2494
work_keys_str_mv AT hunterdavidj biochemicalmarkersofboneturnoverandtheirassociationwithbonemarrowlesions
AT lavalleymichael biochemicalmarkersofboneturnoverandtheirassociationwithbonemarrowlesions
AT lijiang biochemicalmarkersofboneturnoverandtheirassociationwithbonemarrowlesions
AT bauerdougc biochemicalmarkersofboneturnoverandtheirassociationwithbonemarrowlesions
AT nevittmichael biochemicalmarkersofboneturnoverandtheirassociationwithbonemarrowlesions
AT degrootjeroen biochemicalmarkersofboneturnoverandtheirassociationwithbonemarrowlesions
AT poolerobin biochemicalmarkersofboneturnoverandtheirassociationwithbonemarrowlesions
AT eyredavid biochemicalmarkersofboneturnoverandtheirassociationwithbonemarrowlesions
AT guermaziali biochemicalmarkersofboneturnoverandtheirassociationwithbonemarrowlesions
AT galedaniel biochemicalmarkersofboneturnoverandtheirassociationwithbonemarrowlesions
AT tottermansaara biochemicalmarkersofboneturnoverandtheirassociationwithbonemarrowlesions
AT felsondavidt biochemicalmarkersofboneturnoverandtheirassociationwithbonemarrowlesions